Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future—Five-Years’ Single-Institution Experience of 762 Consecutive Patients

Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future—Five-Years’ Single-Institution Experience of 762 Consecutive Patients

The establishment of PARP inhibitors in the treatment of epithelial ovarian carcinoma (EOC) has prompt BRCA assessment at the time of diagnosis. We described our five years of experience of tumor BRCA testing, as part of a multidisciplinary workflow for the management of EOC patients. We used a BRCA...

Full description

Bibliographic Details
Main Authors: Caterina Fumagalli, Ilaria Betella, Alessandra Rappa, Maria di Giminiani, Michela Gaiano, Luigi Antonio De Vitis, Benedetta Zambetti, Davide Vacirca, Francesco Multinu, Konstantinos Venetis, Nicoletta Colombo, Massimo Barberis, Elena Guerini Rocco
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
BRCA
epithelial ovarian carcinoma
NGS
Online Access:https://www.mdpi.com/2072-6694/14/7/1638

Internet

https://www.mdpi.com/2072-6694/14/7/1638

Similar Items